Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
|Articles|April 1, 2005
- Volume 0 0
ACE Inhibitors Lower Pneumonia Threat
Advertisement
Patients who have had a stroke can ward off the risk of pneumonia withangiotensin-converting enzyme (ACE) inhibitors. For the study, theresearchers evaluated the risk of pneumonia in >1000 patients who had hada stroke. The patients involved in the 35-month study were given 1 of 3 treatments:ACE inhibitors, other blood pressure drugs, or a placebo. The datashowed 2.8% of the ACE inhibitor group developed pneumonia, comparedwith 8.5% of the patients in the other 2 groups. (The findings were reportedin Neurology, February 9, 2005.)
Articles in this issue
over 21 years ago
Internet Prescribing 2005over 21 years ago
COMPOUNDING HOTLINEover 21 years ago
Breakfast Cereals Take a Step in the Right Directionover 21 years ago
Refined Carbs Cause Obesityover 21 years ago
Obesity Problematic for Young Transplant Patientsover 21 years ago
High BMI Linked to Dementiaover 21 years ago
When Does Compounding Become Manufacturing?over 21 years ago
Talking to Your Diabetes Patients About Fiberover 21 years ago
Counseling Guide for Avoiding Asthma Triggersover 21 years ago
RA Drug Does Not Alter Cholesterol RatioAdvertisement
Related to this article
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Bridging the Gap: Pharmacist Experiences Obtaining DEA Licenses
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Expert Q&A: Pharmacists Address Pneumococcal Vaccine Hesitancy and Screening Complexity in Transitions of Care
4
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
5